导航
| 统计阶段 | 收益率 | 同类排名 |
|---|---|---|
| 今年以来 | 3.34% | 432/1050 |
| 近一周 | -1.68% | 287/1104 |
| 近一月 | -3.32% | 392/1102 |
| 近一季 | -8.24% | 590/1092 |
| 近半年 | -5.00% | 605/1070 |
| 近一年 | 6.72% | 429/1018 |
| 近两年 | 71.66% | 346/926 |
| 近三年 | 47.17% | 271/834 |
| 成立以来 | 113.40% | - |
| 年份 | 年收益 | 1季度 | 2季度 | 3季度 | 4季度 |
| 2026 | - - |
3.61% 219/1070 |
13.08% 496/1101 |
- - |
- - |
| 2025 | 33.84% 417/1065 |
2.55% 602/1014 |
3.28% 415/1038 |
26.44% 422/1050 |
-0.06% 455/1065 |
| 2024 | 14.56% 186/1011 |
7.87% 52/960 |
-4.93% 630/983 |
11.83% 465/991 |
-0.10% 325/1011 |
| 2023 | -6.42% 236/952 |
3.84% 384/880 |
-2.39% 332/895 |
-0.91% 112/915 |
-6.83% 656/952 |
| 2022 | -12.24% 122/867 |
-8.70% 81/773 |
2.73% 638/806 |
-8.73% 181/845 |
2.53% 296/867 |
| 2021 | 11.13% 231/740 |
3.33% 73/580 |
3.99% 483/659 |
4.08% 146/704 |
-0.64% 466/740 |
| 2020 | 30.26% 346/554 |
-3.34% 240/419 |
15.24% 347/466 |
6.53% 332/517 |
9.77% 364/554 |
| 2019 | 24.07% 318/410 |
25.07% 696/1146 |
-5.84% 767/1228 |
-1.85% 358/390 |
7.34% 266/410 |
| 2018 | - - |
- - |
- - |
-1.64% 283/1000 |
-11.85% 544/1080 |
| 2017 | - - |
- - |
- - |
- - |
- - |
| 2016 | - - |
- - |
- - |
- - |
- - |
| 2015 | - - |
- - |
- - |
- - |
- - |
| 2014 | - - |
- - |
- - |
- - |
- - |
| 2013 | - - |
- - |
- - |
- - |
- - |
| 2012 | - - |
- - |
- - |
- - |
- - |
| 基金名称 | 最新净值 | 季增长率 |
| 招商前沿医疗保健股票A | 0.8316 | 54.00% |
| 招商前沿医疗保健股票C | 0.7978 | 53.69% |
| 招商医药健康产业股票 | 2.5730 | 48.73% |
| 嘉实医疗保健股票 | 2.5780 | 39.05% |
| 广发医药精选股票A | 1.3132 | 38.48% |
| 广发医药精选股票C | 1.2923 | 38.32% |
| 前海开源公共卫生股票A | 0.4690 | 37.42% |
| 前海开源公共卫生股票C | 0.4590 | 37.30% |
| 交银医药创新股票C | 3.0594 | 35.86% |
| 交银医药创新股票A | 2.8810 | 32.85% |
| 博时量化价值股票A VS. 东吴新产业精选股票A(580008) |